Corebridge Financial’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,495
| Closed | -$418K | – | 1389 |
|
|
2025
Q1 | $418K | Buy |
15,495
+1,555
| +11% | +$42K | ﹤0.01% | 1691 |
|
|
2024
Q4 | $746K | Sell |
13,940
-1,053
| -7% | -$56.4K | ﹤0.01% | 1470 |
|
|
2024
Q3 | $681K | Sell |
14,993
-92
| -0.6% | -$4.18K | ﹤0.01% | 1565 |
|
|
2024
Q2 | $632K | Buy |
+15,085
| New | +$632K | ﹤0.01% | 1566 |
|